Imrecoxib is a chemical compound under investigation as an active pharmaceutical ingredient. It has been evaluated in clinical trials for the management of knee osteoarthritis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Imrecoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Triamterene
pharmaceutical raw material
Pasireotide
pharmaceutical raw material
Methacycline hydrochloride
pharmaceutical raw material
Fluticasone furoate
pharmaceutical raw material
4-(4-methylphenyl)-3-(4-methylsulfonylphenyl)-1-propyl-2H-pyrrol-5-one
AXMZZGKKZDJGAZ-UHFFFAOYSA-N
CCCN1CC(=C(C1=O)C2=CC=C(C=C2)C)C3=CC=C(C=C3)S(=O)(=O)C
Sourcing Imrecoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.